Advertisement
Screener

HI TECH PHARMACAL CO INC Share-based Payment Arrangement, Expense

HI TECH PHARMACAL CO INC Share-based Payment Arrangement, Expense

HI TECH PHARMACAL CO INC reported Share-based Payment Arrangement, Expense of $1.14 million for the 3-month period ending 2014-01-31, per its 10-Q filed 2014-03-11.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2014-03-11

  • HI TECH PHARMACAL CO INC share-based payment arrangement, expense for the quarter ending 2014-01-31 was $1.14M, a 10.79% decline year-over-year.
  • HI TECH PHARMACAL CO INC share-based payment arrangement, expense for the quarter ending 2013-10-31 was $1.35M, a 29.97% increase year-over-year.
  • HI TECH PHARMACAL CO INC share-based payment arrangement, expense for the quarter ending 2013-07-31 was $1.34M, a 70.96% increase year-over-year.
  • HI TECH PHARMACAL CO INC share-based payment arrangement, expense for the quarter ending 2013-04-30 was $1.31M, a 102.01% increase year-over-year.
  • HI TECH PHARMACAL CO INC share-based payment arrangement, expense for fiscal 2013 was $4.41M, a 53.69% increase from fiscal 2012.
  • HI TECH PHARMACAL CO INC share-based payment arrangement, expense for fiscal 2012 was $2.87M, a 12.54% increase from fiscal 2011.
  • HI TECH PHARMACAL CO INC share-based payment arrangement, expense for fiscal 2011 was $2.55M.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 12 month
2014-01-31$1.14M
10-Q · filed 2014-03-11
$2.49M
derived: sum of 2 quarters · filed 2014-03-11
$3.84M
10-Q · filed 2014-03-11
$5.14M
derived: sum of 4 quarters · filed 2014-03-11
2013-10-31$1.35M
10-Q · filed 2013-12-10
$2.69M
10-Q · filed 2013-12-10
$4.00M
derived: sum of 3 quarters · filed 2013-12-10
$5.28M
derived: sum of 4 quarters · filed 2013-12-10
2013-07-31$1.34M
10-Q · filed 2013-09-09
$2.65M
derived: sum of 2 quarters · filed 2013-09-09
$3.93M
derived: sum of 3 quarters · filed 2013-09-09
$4.97M
derived: sum of 4 quarters · filed 2013-12-10
2013-04-30$1.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-11
$2.59M
derived: sum of 2 quarters · filed 2013-07-11
$3.63M
derived: sum of 3 quarters · filed 2013-12-10
$4.41M
10-K · filed 2013-07-11
2013-01-31$1.28M
10-Q · filed 2014-03-11
$2.32M
derived: sum of 2 quarters · filed 2013-12-10
$3.10M
10-Q · filed 2014-03-11
$3.75M
derived: sum of 4 quarters · filed 2013-12-10
2012-10-31$1.04M
10-Q · filed 2013-12-10
$1.83M
10-Q · filed 2013-12-10
$2.47M
derived: sum of 3 quarters · filed 2013-12-10
$3.22M
derived: sum of 4 quarters · filed 2013-12-10
2012-07-31$785.00K
10-Q · filed 2013-09-09
$1.43M
derived: sum of 2 quarters · filed 2013-09-09
$2.18M
derived: sum of 3 quarters · filed 2013-09-09
$2.92M
derived: sum of 4 quarters · filed 2013-09-09
2012-04-30$648.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-11
$1.40M
derived: sum of 2 quarters · filed 2013-07-11
$2.14M
derived: sum of 3 quarters · filed 2013-07-11
$2.87M
10-K · filed 2013-07-11
2012-01-31$747.00K
10-Q · filed 2013-03-08
$1.49M
derived: sum of 2 quarters · filed 2013-03-08
$2.22M
10-Q · filed 2013-03-08
2011-10-31$741.00K
10-Q · filed 2012-12-07
$1.48M
10-Q · filed 2012-12-07
2011-07-31$736.00K
10-Q · filed 2012-09-10
2011-04-30$2.55M
10-K · filed 2013-07-11